Buffalo eye practice performs early RayOne Galaxy implant

Fichte, Endl & Elmer Eyecare says Michael J. Endl, M.D., implanted one of the first RayOne Galaxy intraocular lenses in the Northeast on Oct. 13. The new FDA-approved cataract lens is designed to broaden vision at multiple distances and reduce patients’ reliance on glasses.

Why it matters: - The RayOne Galaxy gives cataract patients in Western New York access to one of the newest lens technologies available in the United States. - The lens is designed to reduce dependence on glasses after cataract surgery, which can improve daily vision for reading, computer work and distance viewing. - The RayOne Galaxy is positioned as an option for patients who want broader vision without the halos and glare that can come with some advanced lenses.

What happened: - Michael J. Endl, M.D., of Fichte, Endl & Elmer Eyecare performed one of the very first RayOne Galaxy intraocular lens implants in the Northeast on Oct. 13. - Rayner makes the lens, which the U.S. Food and Drug Administration recently approved. - The procedure took place in Buffalo, giving cataract patients in the area early access to the technology.

The details: - During cataract surgery, the eye’s cloudy natural lens is removed and replaced with an artificial intraocular lens. - A standard monofocal lens usually provides clear vision at one distance, which often leaves patients relying on glasses for near tasks. - The RayOne Galaxy is the world’s first spiral IOL and the first lens designed using artificial intelligence. - The lens uses a spiral optic to manage incoming light and provide a continuous range of vision from distance to intermediate to near. - A toric version is available for patients with astigmatism, allowing both conditions to be treated in a single procedure. - The RayOne Galaxy joins the practice’s range of presbyopia-correcting lenses. - Fichte, Endl & Elmer Eyecare says patients are evaluated individually for eye health, measurements and visual needs before a lens recommendation is made. - Patients can request an appointment online or call 1-800-309-2020. - More information on Dr. Endl’s background and experience is available in the practice’s profile.

Between the lines: - The early implant suggests the practice is trying to move quickly on newly approved cataract technology and capture patients looking for premium lens options. - Dr. Endl’s background in more than 40,000 refractive procedures and FDA clinical trials may help the practice market itself as an early adopter for complex lens implants. - The mention of the PanOptix trifocal lens shows Fichte, Endl & Elmer Eyecare has a history of bringing new lens options to New York State before many peers. - The core tradeoff in advanced cataract lenses remains the same: more range of vision can mean more risk of visual side effects, and the RayOne Galaxy is being framed as a different approach to that problem.

What's next: - Patients interested in the RayOne Galaxy can seek an evaluation to see whether they are candidates. - The practice is likely to continue adding the lens as part of its presbyopia-correcting and astigmatism-correcting options for cataract surgery. - Wider adoption will depend on patient selection, outcomes and how quickly the technology spreads beyond early implant sites.